covaxin’s application rejected: US FDA rejects Ocugen’s emergency use authorization application for Bharat Biotech’s Covaxin

covaxin’s application rejected: US FDA rejects Ocugen’s emergency use authorization application for Bharat Biotech’s Covaxin

Hyderabad/Delhi
Bharat Biotech’s corona vaccine ‘Covaccine’ has suffered a setback in the US. US drug regulator USFDA has rejected Ocugen’s application for emergency use. Ocugen is an American partner firm of Bharat Biotech. The Government of India has given a slow response to the non-approval of Covaxin. He has said that India respects the regulatory system of every country. This move will not affect its vaccine program.

The USFDA has advised OcuGen Inc. to request the Biological License Application (BLA) route with additional data to obtain approval for use of the Indian vaccine. In a statement on Thursday, OcuGen said it would file a BLA for Covaccine in accordance with the FDA’s advice.

Covaxin vs Covishield: Amidst the controversy and questions raised on the effect of Covaxin, Bharat Biotech announced – will conduct the fourth phase trial to check the real effect
What is BLA?
BLA is the FDA’s ‘Full Approval’ arrangement. Under this, drugs and vaccines are approved. In such a situation, it may take some more time for Covaccine to get US approval.

“The company will no longer seek emergency access permission (EUA) for Covaccine,” OcuGen said. The FDA has given a response to the master file to Okuzane. It has been advised that OcuGen should file a BLA request instead of an EUA application for its vaccine. Along with this a request has also been made for some additional information and data.

Covaxin Trial For Children: Screening started in AIIMS for Covaxin Trial on children, know what happens in it
The company is discussing
OcuGen said this could delay the launch of Covaccine in the US. OcuGen is in discussion with the FDA to understand the additional information required for the BLA request. The company anticipates that an additional clinical trial data will be needed for the application to be approved.

See also  easing of restrictions: The war with Corona continues, do not be careless, PM appeals to the countrymen

“While we were very close to finalizing our EUA application, the FDA has advised us to make the request via BLA,” said Shankar Musunuri, CEO and Co-Founder of Ocugen. It will take longer, but we are determined to bring the vaccine to the US.

covaxin

#covaxins #application #rejected #FDA #rejects #Ocugens #emergency #authorization #application #Bharat #Biotechs #Covaxin

Leave a Comment

close